Literature DB >> 31441782

Reactivation of Alopecia Areata After Dupilumab Therapy for Atopic Dermatitis.

Jocelyn M Carnicle1, Aleksi J Hendricks2, Vivian Y Shi3.   

Abstract

We present a case report of a 42-year-old woman with severe atopic dermatitis (AD) and history of alopecia areata (AA), which had been in remission for more than 5 years. She was treated with dupilumab for AD, and 4 months after initiating treatment, she developed a rapidly progressive reactivation of AA in an androgenic alopecia pattern. Alopecia resolved after a single intramuscular triamcinolone injection while the patient remained on dupilumab. This is the seventh report to date of dupilumab-associated alopecia but is the first case documenting reactivation of previous AA. Alopecia occurring after dupilumab initiation raises suspicion for a possible unrecognized adverse effect of dupilumab in AD patients.
Copyright © 2019 American Contact Dermatitis Society. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 31441782     DOI: 10.1097/DER.0000000000000512

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  5 in total

Review 1.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

2.  Massive Acute Alopecia of the Scalp in a Patient Treated with Dupilumab.

Authors:  Rosella Gallo; Ilaria Trave; Aurora Parodi
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

3.  Resolution of dupilumab-associated alopecia areata with dosage modification.

Authors:  Maansi Kulkarni; Craig A Rohan; David Morris; Jeffrey B Travers
Journal:  JAAD Case Rep       Date:  2022-02-17

4.  Short communication: Comments on hair disorders associated with dupilumab based on VigiBase.

Authors:  Sunny Park; So Hyang Park; Young Joo Byun; Soo An Choi
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

5.  Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata.

Authors:  Reiko Kageyama; Taisuke Ito; Shiho Hanai; Naomi Morishita; Shinsuke Nakazawa; Toshiharu Fujiyama; Tetsuya Honda; Yoshiki Tokura
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.